Home/Pipeline/Recombinant Zoster Vaccine (Adenovirus Vector)

Recombinant Zoster Vaccine (Adenovirus Vector)

Herpes Zoster Prevention

Phase 2Active

Key Facts

Indication
Herpes Zoster Prevention
Phase
Phase 2
Status
Active
Company

About CanSino Biologics

A leading Chinese vaccine developer leveraging adenovirus vector technology to create innovative vaccines for global infectious disease prevention.

View full company profile

Therapeutic Areas